JP Patent

JP6782756B2 — Ｋｉｔに関連する疾患を治療するために有用な化合物の製法と中間体化合物

Assigned to ブループリント メディシンズ コーポレイション · Expires 2020-11-11 · 6y expired

What this patent protects

Patent listed against Ayvakit.

Drugs covered by this patent

Patent Metadata

Patent number
JP6782756B2
Jurisdiction
JP
Classification
—
Expires
2020-11-11
Drug substance claim
No
Drug product claim
No
Assignee
ブループリント メディシンズ コーポレイション
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.